FTC Files Amicus Brief in Antitrust Case Alleging Johnson & Johnson Monopoly Conduct
The Federal Trade Commission filed an amicus brief in an antitrust case in which drug manufacturer Johnson & Johnson is alleged to have illegally maintained a monopoly through anticompetitive conduct, per the FTC's June .
At a glance
- The FTC filed an amicus brief in an antitrust case involving Johnson & Johnson, per the agency's June 23, 2026 release.
- The underlying case alleges Johnson & Johnson illegally maintained a monopoly through anticompetitive conduct, per the FTC.
VERDICT — CONFIRMED

The Federal Trade Commission filed an amicus brief in an antitrust case in which drug manufacturer Johnson & Johnson is alleged to have illegally maintained a monopoly through anticompetitive conduct, per the FTC's June 23 press release. The agency framed the filing as an effort to protect consumers from pharmaceutical monopolies, per the release. The allegations against Johnson & Johnson are claims in litigation, not adjudicated findings.
Key facts on file
- The FTC filed an amicus brief in an antitrust case involving Johnson & Johnson, per the agency's June 23, 2026 release.
- The underlying case alleges Johnson & Johnson illegally maintained a monopoly through anticompetitive conduct, per the FTC.